Does Rallies show 13F holders for TIVC?

Yes. Rallies tracks hedge fund and 13F ownership data for TIVC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is TIVC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TIVC. It does not provide personalized investment advice.

TIVC (Tivic Health Systems, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Tivic Health Systems, Inc. Common Stock (TIVC) is a publicly traded Healthcare sector company. As of May 21, 2026, TIVC trades at $1.40 with a market cap of $4.03M and a P/E ratio of -0.18. TIVC moved +7.69% today. Year to date, TIVC is -39.91%; over the trailing twelve months it is -80.34%. Its 52-week range spans $0.72 to $15.64. Rallies surfaces TIVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns TIVC stock?

Hedge funds tracked by Rallies that own TIVC include Two Sigma, Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tivic Health Systems, Inc. Common Stock.

TIVC Key Metrics

Key financial metrics for TIVC
Metric	Value
Price	$1.40
Market Cap	$4.03M
P/E Ratio	-0.18
EPS	$-7.74
Dividend Yield	0.00%
52-Week High	$15.64
52-Week Low	$0.72
Volume	352.14K
Avg Volume	0
Revenue (TTM)	$-70.00K
Net Income	$-13.58M
Gross Margin	0.00%

Top Hedge Funds Holding TIVC

Two Sigma holds 28.52K shares of TIVC, changed +0.00% as of Sep 30, 2024.
Renaissance Technologies holds 17.60K shares of TIVC, changed +0.00% as of Sep 30, 2024.
Citadel Advisors holds 14.55K shares of TIVC, changed +0.00% as of Jun 30, 2024.
Two Sigma holds 12.15K shares of TIVC, changed +0.00% as of Dec 31, 2024.

Latest TIVC News

Valion Bio Rebrands, Ticker VBIO, Poised for Nine-Figure BARDA Contract — Apr 23, 2026
Tivic CEO to detail NIAID-backed Entolimod GI-ARS preclinical study at April conference — Mar 27, 2026
Tivic Health Secures Entolimod Rights, Launches CDMO Arm with $12.6M Cash — Mar 25, 2026
Biotech Veteran Michael Handley Tapped as Tivic Health CEO to Drive CDMO Expansion — Mar 4, 2026
Tivic Health Systems Scales Entolimod Manufacturing 200x, Achieves Reproducible Purity — Jan 12, 2026

Recent TIVC Insider Trades

Bolton Sheryle bought 10.00K (~$10.40K) on Apr 15, 2026.
Valauri Christina Rizopoulos bought 19.00K (~$18.01K) on Apr 1, 2026.

TIVC Analyst Consensus

TIVC analyst coverage data. Average price target: $0.00.

Common questions about TIVC

Who owns TIVC stock?: Hedge funds tracked by Rallies that own TIVC include Two Sigma, Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Tivic Health Systems, Inc. Common Stock.
Does Rallies show 13F holders for TIVC?: Yes. Rallies tracks hedge fund and 13F ownership data for TIVC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TIVC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TIVC. It does not provide personalized investment advice.